Bernhard Tribukait

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Ejection Fraction

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Bernhard Tribukait, Per-Olof Lundgren, Anders Kjellman, Ulf Norming, Claes R Nyman, Kiran Jagarlmundi, Ove Gustafsson
Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer. International journal of molecular sciences 24 (6) (2023)
Bernhard Tribukait, Per-Olof Lundgren, Anders Kjellman, Ulf Norming, Claes R Nyman, Kiran Jagarlmundi, Ove Gustafsson
Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer. International journal of molecular sciences 24 (6) (2023)
Bernhard Tribukait, Per-Olof Lundgren, Anders Kjellman, Ulf Norming, Claes R Nyman, Kiran Jagarlmundi, Ove Gustafsson
Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer. International journal of molecular sciences 24 (6) (2023)
Per-Olof Lundgren, Bernhard Tribukait, Anders Kjellman, Ulf Norming, Kiran Jagarlmudi, Ove Gustafsson
Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer. The Prostate 82 (8) (2022)
Bernhard Tribukait
Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer. Cancers 13 (21) (2021)
Bernhard Tribukait
Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume. BMC cancer 20 (1) (2020)